Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Date
2025Author(s)
Avagimyan, A. A.
Sheibani, M.
Trofimenko, A. I.
Lysov, E. E.
Khamidova, F. M.
Aznauryan, A. Z.
Sukiasyan, L. M.
Sahakyan, K. T.
Gevorgyan, T. R.
Tatoyan, M. R.
Mkrtchyan, G. L.
Meltonyan, G. L.
Petrosyan, A. R.
Petrosyan, A. R.
Martemyanova, L. A.
Petrosyan, R. R.
Urazova, O. I.
Pogosova, N. V.
Sarrafzadegan, N.
Metadata
Show full item recordCitation
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2) / A. A. Avagimyan, M. Sheibani, A. I. Trofimenko [et al.] // Innovative Medicine of Kuban. – 2025. – Vol. 10, №. 1. – P. 101–109. – DOI: 10.35401/2541-9897-2025-10-1-101-109.
Subjects
hepatoprotection
neuroprotection
retinoprotection
oncoprotection
dapagliflozin
empagliflozin
canagliflozin
Collections
- 2025 [51]